TrumpRx Launches Today: How Medicare's $350 Ozempic Deal Will Reshape America's Weight Loss Market
Trump administration's deal with Eli Lilly and Novo Nordisk slashes GLP-1 drug prices to $350/month through TrumpRx.gov, starting January 2026. Medicare beneficiaries pay just $50 copays.